PCN50 COSTS OF TREATMENT WITH ANGIOGENESIS INHIBITORS (AIS) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC): RESULTS FROM A MEDICAL CHART REVIEW STUDY

Autor:	P Ramamurthy, Duh, Kristina Chen, William Oh, A. Luka, S Whittemore, DF McDermott, TK Choueiri, Maureen P. Neary, Sujata P. Sarda, L. Antras
Rok vydání:	2010
Předmět:	Oncology medicine.medical_specialty Review study business.industry Angiogenesis Medical record Health Policy Public Health Environmental and Occupational Health medicine.disease Renal cell carcinoma Internal medicine medicine In patient business health care economics and organizations
Zdroj:	Value in Health. 13(3)
ISSN:	1098-3015
DOI:	10.1016/s1098-3015(10)72139-2
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::319eea29c283a07cc39c5c9fe8b2dd0d Zobrazit plný text záznamu Full Text from ScienceDirect Plný text